[Correlation of epidermal growth factor receptor mutations and HER2/3 protein expression with clinical outcome in advanced non-small cell lung cancer patients treated with gefitinib].

Abstract excerpt

BACKGROUND AND OBJECTIVE: The effect of gefitinib on advanced non-small cell lung cancer (NSCLC) was various. How to choose the sensitive patients and improve the effect was difficulty in clinic. This study was to assess the correlation of epidermal growth factor receptor (EGFR) mutations and HER2/3 protein expression with the effect of gefitinib on Chinese patients with advanced NSCLC. METHODS: From May 2002 to...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Carcinoma, Squamous Cell
• Share to Gefitinib